Factors associated with silent cerebral events during catheter ablation for atrial fibrillation in the era of uninterrupted oral anticoagulation therapy
Use of direct thrombin inhibitor on the day of atrial fibrillation ablation decreases incidence of silent cerebral ischemia detected by magnetic resonance imaging
Intracardiac and extracardiac expression of pro-fibrotic microRNAs in atrial fibrillation -Implication for cardiac specific biomarkers for atrial remodeling-